Please use this identifier to cite or link to this item:
Title: Future fertility of women cancer survivors : the progress in fertility preservation
Authors: Farrugia, Amanda
Calleja-Agius, Jean
Keywords: Chemotherapy
Drugs -- Side effects
Infertility -- Prevention
Fertility -- Effect of drugs on
Cancer -- Treatment -- Complications
Issue Date: 2020
Publisher: Ecronicon Open Access
Citation: Farrugia, A., & Calleja-Agius, J. (2020). Future fertility of women cancer survivors : the progress in fertility preservation. EC Gynaecology, 9(3), 01-08.
Abstract: Diminished ovarian reserve (DOR) has devastating implications for the affected female in terms of quality of life, fertility, fecundity and overall well-being. DOR can be exacerbated by the use of chemotherapy and gynaecological surgeries. Analysis of the gonadotoxicity and efficacy of chemotherapeutic regimens currently available and the techniques for gynaecological surgeries, allows for the most appropriate regimen or technique to be selected following a risk-benefit ratio analysis. This should be done in conjunction with fertility preservation strategies including cryopreservation, ovarian transposition and suppression, and pharmacological agents. New approaches using fertoprotective agents need to be evaluated in order to keep up with the demand for oncofertility. This ensures the least possible damage to the ovarian environment and the utmost preservation of the follicular pool.
Appears in Collections:Scholarly Works - FacM&SAna

Files in This Item:
File Description SizeFormat 
Future_fertility_of_women_cancer_survivors_the_progress_in_fertility_preservation_2020.pdf281.08 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.